Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 May;43(5):444-50.
doi: 10.1136/jmg.2005.031880. Epub 2005 May 20.

A second locus for Aicardi-Goutieres syndrome at chromosome 13q14-21

M Ali  1 , L J Highet, D Lacombe, C Goizet, M D King, U Tacke, M S van der Knaap, L Lagae, C Rittey, H G Brunner, H van Bokhoven, B Hamel, Y A Oade, A Sanchis, I Desguerre, D Cau, N Mathieu, M L Moutard, P Lebon, D Kumar, A P Jackson, Y J Crow
Affiliations

A second locus for Aicardi-Goutieres syndrome at chromosome 13q14-21

M Ali et al. J Med Genet. 2006 May.

Abstract

Background: Aicardi-Goutières syndrome (AGS) is an autosomal recessive, early onset encephalopathy characterised by calcification of the basal ganglia, chronic cerebrospinal fluid lymphocytosis, and negative serological investigations for common prenatal infections. AGS may result from a perturbation of interferon alpha metabolism. The disorder is genetically heterogeneous with approximately 50% of families mapping to the first known locus at 3p21 (AGS1).

Methods: A genome-wide scan was performed in 10 families with a clinical diagnosis of AGS in whom linkage to AGS1 had been excluded. Higher density genotyping in regions of interest was also undertaken using the 10 mapping pedigrees and seven additional AGS families.

Results: Our results demonstrate significant linkage to a second AGS locus (AGS2) at chromosome 13q14-21 with a maximum multipoint heterogeneity logarithm of the odds (LOD) score of 5.75 at D13S768. The AGS2 locus lies within a 4.7 cM region as defined by a 1 LOD-unit support interval.

Conclusions: We have identified a second AGS disease locus and at least one further locus. As in a number of other conditions, genetic heterogeneity represents a significant obstacle to gene identification in AGS. The localisation of AGS2 represents an important step in this process.

PubMed Disclaimer

Conflict of interest statement

Competing interests: none declared

References

    1. Aicardi J, Goutières F. A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol 19841549–54. - PubMed
    1. Goutières F, Aicardi J, Barth P G, Lebon P. Aicardi‐Goutières syndrome: an update and results of interferon‐α studies. Ann Neurol 199844900–907. - PubMed
    1. Garrec M L, Doret M, Pasquier J C, Till M, Lebon P, Buenerd A, Escalon J, Gaucherand P. Prenatal diagnosis of Aicardi‐Goutières syndrome. Prenat Diagn 20052528–30. - PubMed
    1. Black D N, Watters G V, Andermann E, Dumont C, Kabay M, Kaplan P, Meagher‐Villemure K, Michaud J, O'Gorman G, Reece E. Encephalitis among Cree children in Northern Québec. Ann Neurol 198824483–489. - PubMed
    1. Dale R C, Tang S P, Heckmatt J Z, Tatnall F M. Familial systemic lupus erythematosus and congenital infection‐like syndrome. Neuropediatrics 200031155–158. - PubMed

Publication types